Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: A randomized clinical trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 3, 2009, Pages 703-711

  Hecht Dolnik, Marketa ^a   Barkan, Howard ^b   Taharka, Ananse ^a   Loftus, John ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRAIN; ERYTHROCYTE; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PATIENT MONITORING; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TUBE;

ANALYSIS OF VARIANCE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BODY MASS INDEX; CORONARY ARTERY BYPASS; FEMALE; HETASTARCH; HUMANS; INTRAOPERATIVE CARE; LENGTH OF STAY; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 68749090837     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.02.035     Document Type: Article

References (30)

1. Avorn J., Patel M., Levin R., and Winkelmayer W.C. Hetastarch and bleeding complications after coronary artery surgery. Chest 124 (2003) 1437-1442
2. London M.J., Ho J.S., Triedman J.K., et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 97 (1989) 785-797
3. Wilkes M.M., Navickis R.J., and Sibbald W.J. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis of postoperative bleeding. Ann Thorac Surg 72 (2003) 527-533
4. Knutson J.E., Deering J.A., Hall F.W., et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery?. Anesth Analg 90 (2000) 801-807
5. Alexander J.C. Hetastarch in perioperative volume expansion. Chest 124 (2003) 1194-1196
6. Shander A., Rijhwani T., and Moskowitz D. Blood and starch in cardiac surgery. Chest 125 (2004) 2369-2370
7. Wilkes M.M., and Navickis R.J. Hydroxyethyl starch-induced postoperative bleeding in cardiac surgery patients: more trials needed?. Chest 126 (2004) 311-312
8. Sade R.M., Stroud M.R., Crawford Jr. F.A., Kratz J.M., Dearing J.P., and Bartles D.M. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 89 (1985) 713-722
9. Boldt J., Knothe C., Zickmann B., et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76 (1993) 1185-1190
10. Warren B.B., and Durieux M.E. Hydroxyethyl starch: safe or not?. Anesth Analg 84 (1997) 206-212
11. Haynes G.R. Fluid management in cardiac surgery: is one hydroxyethyl starch solution safer than another?. J Cardiothorac Vasc Anesth 20 (2006) 916-917
12. Haynes G.R., Havidich J.E., and Payne K.J. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101 (2004) 560-561
13. Boldt J. Volume therapy in cardiac surgery: are Americans different from Europeans?. J Cardiothorac Vasc Anesth 20 (2006) 98-105
14. Bunn F., Trivedi D., and Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev (2008) CD001319
15. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103 (2005) 654-660
16. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systematic review of randomized controlled trials. BMJ 317 (1998) 235-240
17. Boldt J. New light on intravascular volume replacement regimens: what did we learn from the past three years?. Anesth Analg 97 (2003) 1595-1604
18. Herwaldt L.A., Swartzendruber S.K., Edmond M.B., et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 19 (1998) 9-16
19. Sedrakyan A., Gondek K., Paltiel D., and Elefteriades J.A. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 123 (2003) 1853-1857
20. Boldt J., Muller M., Mentges D., et al. Volume therapy in the critically ill: is there a difference?. Intensive Care Med 24 (1998) 28-36
21. Boldt J., Suttner S., Kumle B., and Huttner I. Cost analysis of different volume replacement strategies in anesthesia. Infusionstherapie und Transfusionsmedizin 27 (2000) 38-43
22. Pepper J. Controversies in off-pump coronary artery surgery. Clin Med Res 3 (2005) 27-33
23. Raja S.G. Pump or no pump for coronary artery bypass: current best available evidence. Tex Heart Inst J 32 (2005) 489-501
24. Lo B., Fijnheer R., Castigliego D., et al. Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass. Anesth Analg 99 (2004) 634-640
25. Ascione R., Williams S., Lloyd C.T., et al. Reduced postoperative blood loss and transfusion requirement after beating-heart operations: a prospective randomized study. J Thorac Cardiovasc Surg 121 (2001) 689-696
26. Reston J.T., Tregear S.J., and Turkelson C.M. Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 1510-1515
27. Jones B., Jarvis P., Lewis J.A., and Ebbutt A.F. Trials to assess equivalence: the importance of rigorous methods. BMJ 313 (1996) 36-39 Erratum in: BMJ. 1996;313:550
28. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc B 57 (1995) 289-300
29. Alderson P., Bunn F., Li Wan Po A., et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database of Systematic Reviews (2004) 4 Art. CD001208
30. Goodenough L.T., Johnston M.F.M., Toy P.T.C.Y., et al. The variability of transfusion practice in coronary artery bypass surgery. JAMA 265 (1991) 86-90